| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ion channel regulator activity | 3.67e-04 | 162 | 42 | 4 | GO:0099106 | |
| GeneOntologyMolecularFunction | channel regulator activity | 4.81e-04 | 174 | 42 | 4 | GO:0016247 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 5.09e-04 | 16 | 42 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 5.14e-04 | 177 | 42 | 4 | GO:0141108 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 9.45e-04 | 363 | 42 | 5 | GO:0106310 | |
| GeneOntologyBiologicalProcess | regulation of angiotensin-activated signaling pathway | 2.54e-05 | 4 | 43 | 2 | GO:0110061 | |
| GeneOntologyBiologicalProcess | positive regulation of vesicle transport along microtubule | 4.23e-05 | 5 | 43 | 2 | GO:1901610 | |
| GeneOntologyBiologicalProcess | regulation of vesicle transport along microtubule | 6.33e-05 | 6 | 43 | 2 | GO:1901608 | |
| GeneOntologyBiologicalProcess | vesicle transport along microtubule | 1.64e-04 | 51 | 43 | 3 | GO:0047496 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 1.76e-04 | 253 | 43 | 5 | GO:0099111 | |
| GeneOntologyBiologicalProcess | regulation of circadian rhythm | 1.78e-04 | 135 | 43 | 4 | GO:0042752 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 1.85e-04 | 256 | 43 | 5 | GO:0006470 | |
| GeneOntologyBiologicalProcess | protein localization to axon | 2.31e-04 | 11 | 43 | 2 | GO:0099612 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 2.34e-04 | 145 | 43 | 4 | GO:0001578 | |
| GeneOntologyBiologicalProcess | regulation of organelle transport along microtubule | 2.77e-04 | 12 | 43 | 2 | GO:1902513 | |
| GeneOntologyCellularComponent | PTW/PP1 phosphatase complex | 8.62e-05 | 7 | 43 | 2 | GO:0072357 | |
| MousePheno | abnormal circulating mineral level | CUL3 FNIP1 FAM20C NAA35 SLC38A10 SLC46A3 PRKCZ SGSM1 AGAP9 DNAH5 C16orf89 | 5.24e-05 | 982 | 39 | 11 | MP:0006357 |
| MousePheno | dental pulp necrosis | 7.54e-05 | 5 | 39 | 2 | MP:0013251 | |
| MousePheno | abnormal circulating iron level | 1.03e-04 | 170 | 39 | 5 | MP:0004152 | |
| MousePheno | abnormal mineral level | CUL3 FNIP1 FAM20C NAA35 SLC38A10 SLC46A3 PRKCZ SGSM1 AGAP9 DNAH5 C16orf89 | 1.10e-04 | 1066 | 39 | 11 | MP:0000192 |
| MousePheno | increased circulating iron level | 1.16e-04 | 91 | 39 | 4 | MP:0008810 | |
| MousePheno | abnormal mineral homeostasis | CUL3 FNIP1 FAM20C NAA35 SLC38A10 SLC46A3 PRKCZ SGSM1 AGAP9 DNAH5 C16orf89 | 1.20e-04 | 1076 | 39 | 11 | MP:0005636 |
| MousePheno | increased circulating mineral level | 2.77e-04 | 626 | 39 | 8 | MP:0014547 | |
| MousePheno | abnormal iron level | 3.29e-04 | 218 | 39 | 5 | MP:0001770 | |
| MousePheno | abnormal iron homeostasis | 3.66e-04 | 223 | 39 | 5 | MP:0005637 | |
| MousePheno | increased iron level | 3.82e-04 | 124 | 39 | 4 | MP:0014541 | |
| MousePheno | abnormal ion homeostasis | CUL3 FNIP1 FAM20C NAA35 SLC38A10 SLC46A3 PRKCZ SGSM1 AGAP9 DNAH5 C16orf89 | 3.95e-04 | 1232 | 39 | 11 | MP:0001765 |
| MousePheno | increased mineral level | 4.30e-04 | 668 | 39 | 8 | MP:0014535 | |
| Domain | STPPase_N | 1.48e-05 | 3 | 42 | 2 | PF16891 | |
| Domain | STPPase_N | 1.48e-05 | 3 | 42 | 2 | IPR031675 | |
| Domain | Pkinase_C | 7.79e-05 | 37 | 42 | 3 | IPR017892 | |
| Domain | Pkinase_C | 1.14e-04 | 42 | 42 | 3 | PF00433 | |
| Domain | AGC-kinase_C | 2.70e-04 | 56 | 42 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.70e-04 | 56 | 42 | 3 | PS51285 | |
| Domain | S_TK_X | 2.70e-04 | 56 | 42 | 3 | SM00133 | |
| Domain | C1_1 | 2.84e-04 | 57 | 42 | 3 | PF00130 | |
| Domain | COS_domain | 3.21e-04 | 12 | 42 | 2 | IPR017903 | |
| Domain | COS | 3.21e-04 | 12 | 42 | 2 | PS51262 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 3.79e-04 | 13 | 42 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 3.79e-04 | 13 | 42 | 2 | PS00125 | |
| Domain | PP2Ac | 3.79e-04 | 13 | 42 | 2 | SM00156 | |
| Domain | ZF_DAG_PE_1 | 4.00e-04 | 64 | 42 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 4.00e-04 | 64 | 42 | 3 | PS50081 | |
| Domain | C1 | 4.19e-04 | 65 | 42 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 4.38e-04 | 66 | 42 | 3 | IPR002219 | |
| Domain | Aa_trans | 6.57e-04 | 17 | 42 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 6.57e-04 | 17 | 42 | 2 | IPR013057 | |
| Domain | DAG/PE-bd | 1.01e-03 | 21 | 42 | 2 | IPR020454 | |
| Domain | Calcineurin-like_PHP_ApaH | 1.80e-03 | 28 | 42 | 2 | IPR004843 | |
| Domain | Metallophos | 1.80e-03 | 28 | 42 | 2 | PF00149 | |
| Domain | Metallo-depent_PP-like | 2.06e-03 | 30 | 42 | 2 | IPR029052 | |
| Domain | - | 2.06e-03 | 30 | 42 | 2 | 3.60.21.10 | |
| Domain | Znf-RING_LisH | 2.65e-03 | 34 | 42 | 2 | IPR027370 | |
| Domain | zf-RING_UBOX | 2.65e-03 | 34 | 42 | 2 | PF13445 | |
| Domain | EF-hand_1 | 4.81e-03 | 152 | 42 | 3 | PF00036 | |
| Domain | EFh | 5.36e-03 | 158 | 42 | 3 | SM00054 | |
| Domain | fn3 | 5.74e-03 | 162 | 42 | 3 | PF00041 | |
| Domain | EF_Hand_1_Ca_BS | 7.10e-03 | 175 | 42 | 3 | IPR018247 | |
| Domain | FN3 | 8.27e-03 | 185 | 42 | 3 | SM00060 | |
| Domain | Ser/Thr_kinase_AS | 8.29e-03 | 357 | 42 | 4 | IPR008271 | |
| Domain | S_TKc | 8.45e-03 | 359 | 42 | 4 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 8.70e-03 | 362 | 42 | 4 | PS00108 | |
| Domain | FN3 | 1.01e-02 | 199 | 42 | 3 | PS50853 | |
| Domain | Protein_kinase_ATP_BS | 1.02e-02 | 379 | 42 | 4 | IPR017441 | |
| Domain | Pkinase | 1.04e-02 | 381 | 42 | 4 | PF00069 | |
| Domain | BBOX | 1.05e-02 | 69 | 42 | 2 | SM00336 | |
| Domain | EF_HAND_1 | 1.08e-02 | 204 | 42 | 3 | PS00018 | |
| Domain | - | 1.11e-02 | 71 | 42 | 2 | 4.10.45.10 | |
| Domain | zf-B_box | 1.14e-02 | 72 | 42 | 2 | PF00643 | |
| Domain | FN3_dom | 1.15e-02 | 209 | 42 | 3 | IPR003961 | |
| Domain | ConA-like_dom | 1.30e-02 | 219 | 42 | 3 | IPR013320 | |
| Domain | ZF_BBOX | 1.40e-02 | 80 | 42 | 2 | PS50119 | |
| Domain | Znf_B-box | 1.43e-02 | 81 | 42 | 2 | IPR000315 | |
| Domain | EF_HAND_2 | 1.50e-02 | 231 | 42 | 3 | PS50222 | |
| Domain | PH_dom-like | 1.51e-02 | 426 | 42 | 4 | IPR011993 | |
| Domain | EF_hand_dom | 1.52e-02 | 232 | 42 | 3 | IPR002048 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 4.01e-06 | 115 | 30 | 5 | M9387 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 8.78e-05 | 41 | 30 | 3 | M39655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE | 1.22e-04 | 8 | 30 | 2 | M47933 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX | 2.85e-04 | 12 | 30 | 2 | M47887 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE | 2.85e-04 | 12 | 30 | 2 | M47891 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 4.32e-04 | 70 | 30 | 3 | M3115 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 4.32e-04 | 70 | 30 | 3 | M938 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION | 5.16e-04 | 16 | 30 | 2 | M48235 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 7.32e-04 | 19 | 30 | 2 | MM1361 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 7.32e-04 | 19 | 30 | 2 | M27423 | |
| Pathway | WP_KCNQ2RELATED_EPILEPSIES | 7.32e-04 | 19 | 30 | 2 | M48320 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 7.32e-04 | 19 | 30 | 2 | M9152 | |
| Pathway | WP_FOCAL_ADHESION | 7.92e-04 | 199 | 30 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.92e-04 | 199 | 30 | 4 | M7253 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 8.22e-04 | 201 | 30 | 4 | M39605 | |
| Pathway | WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS | 8.97e-04 | 21 | 30 | 2 | M39343 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.02e-03 | 94 | 30 | 3 | M1041 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.08e-03 | 23 | 30 | 2 | M41817 | |
| Pathway | WP_NRF2ARE_REGULATION | 1.08e-03 | 23 | 30 | 2 | M39761 | |
| Pathway | REACTOME_TRIGLYCERIDE_CATABOLISM | 1.17e-03 | 24 | 30 | 2 | M10064 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.17e-03 | 24 | 30 | 2 | M27553 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.27e-03 | 25 | 30 | 2 | MM15608 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 1.38e-03 | 26 | 30 | 2 | M247 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 1.38e-03 | 26 | 30 | 2 | M628 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.45e-03 | 106 | 30 | 3 | M27077 | |
| Pathway | PID_RAS_PATHWAY | 1.84e-03 | 30 | 30 | 2 | M269 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 1.87e-03 | 116 | 30 | 3 | M2164 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 2.07e-03 | 120 | 30 | 3 | M48233 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 26671463 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CUL3 STK11 PRKCA FAM20C SLC46A3 PRKCZ MYO15A TMBIM1 SRI C16orf89 | 3.46e-07 | 1016 | 43 | 10 | 19056867 |
| Pubmed | 6.49e-07 | 251 | 43 | 6 | 27507650 | ||
| Pubmed | RGS12 polarizes the GPSM2-GNAI complex to organize and elongate stereocilia in sensory hair cells. | 7.93e-07 | 15 | 43 | 3 | 36260679 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 17786270 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 16407220 | ||
| Pubmed | Differential activation of adenylyl cyclase by protein kinase C isoenzymes. | 1.49e-06 | 2 | 43 | 2 | 8206971 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 18354190 | ||
| Pubmed | PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells. | 1.49e-06 | 2 | 43 | 2 | 23176181 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 8856079 | ||
| Pubmed | Rapamycin-sensitive phosphorylation of PKC on a carboxy-terminal site by an atypical PKC complex. | 1.49e-06 | 2 | 43 | 2 | 10339425 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 9882500 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 33556457 | ||
| Pubmed | Mutually exclusive binding of PP1 and RNA to AKAP149 affects the mitochondrial network. | 4.48e-06 | 3 | 43 | 2 | 19074462 | |
| Pubmed | Isoforms of protein kinase C and their distribution in human adrenal cortex and tumors. | 4.48e-06 | 3 | 43 | 2 | 11740573 | |
| Pubmed | 1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription. | 4.48e-06 | 3 | 43 | 2 | 25073485 | |
| Pubmed | Protein phosphatase 1 (PP1) is a post-translational regulator of the mammalian circadian clock. | 4.48e-06 | 3 | 43 | 2 | 21712997 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 17965019 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 12643789 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 10617144 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 12138106 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 7857673 | ||
| Pubmed | Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells. | 4.48e-06 | 3 | 43 | 2 | 11739654 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 11588169 | ||
| Pubmed | Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin/+ mice. | 4.48e-06 | 3 | 43 | 2 | 16849539 | |
| Pubmed | Over-expression of protein kinase C isoforms (α, δ, θ and ζ) in squamous cervical cancer. | 4.48e-06 | 3 | 43 | 2 | 21895402 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 9882488 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 23499489 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 23040068 | ||
| Pubmed | Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. | 8.94e-06 | 4 | 43 | 2 | 16131488 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 10194355 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 15499829 | ||
| Pubmed | Activation and substrate specificity of the human protein kinase C alpha and zeta isoenzymes. | 8.94e-06 | 4 | 43 | 2 | 8375396 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 10880350 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 15226296 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 21645497 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 22768081 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 10807923 | ||
| Pubmed | Nuclear protein phosphatase-1 regulates HIV-1 transcription. | 8.94e-06 | 4 | 43 | 2 | 12788939 | |
| Pubmed | Expression of protein kinase C isoforms and interleukin-1beta in myofibrillar myopathy. | 8.94e-06 | 4 | 43 | 2 | 15159477 | |
| Pubmed | Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. | 8.94e-06 | 4 | 43 | 2 | 23277204 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 12016225 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 12221103 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 28476658 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 12226088 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 17202132 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 10770950 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 12036952 | ||
| Pubmed | N-CoR controls differentiation of neural stem cells into astrocytes. | 8.94e-06 | 4 | 43 | 2 | 12410313 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 24902662 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 21835890 | ||
| Pubmed | Protein kinase C isoforms have differential roles in the regulation of human sebocyte biology. | 1.49e-05 | 5 | 43 | 2 | 22475757 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 31431478 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 23197154 | ||
| Pubmed | Characterization of PDK2 activity against protein kinase B gamma. | 1.49e-05 | 5 | 43 | 2 | 12162751 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 19581931 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 22801782 | ||
| Pubmed | betaII protein kinase C is required for the G2/M phase transition of cell cycle. | 1.49e-05 | 5 | 43 | 2 | 8663071 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 28615442 | ||
| Pubmed | Association of the type 1 protein phosphatase PP1 with the A-kinase anchoring protein AKAP220. | 1.49e-05 | 5 | 43 | 2 | 10209101 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 25487150 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 11145703 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 20424263 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 28426968 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 2590242 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 12624094 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 12016208 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 11551964 | ||
| Pubmed | The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. | 1.49e-05 | 5 | 43 | 2 | 17511879 | |
| Pubmed | The nuclear envelope protein, LAP1B, is a novel protein phosphatase 1 substrate. | 1.49e-05 | 5 | 43 | 2 | 24116158 | |
| Pubmed | The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. | 1.49e-05 | 5 | 43 | 2 | 7522330 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 21190563 | ||
| Pubmed | Protein kinase C-theta is specifically localized on centrosomes and kinetochores in mitotic cells. | 2.23e-05 | 6 | 43 | 2 | 9854032 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 20815813 | ||
| Pubmed | Isoform-specific contribution of protein kinase C to prion processing. | 2.23e-05 | 6 | 43 | 2 | 18722532 | |
| Pubmed | Amplitude control of protein kinase C by RINCK, a novel E3 ubiquitin ligase. | 2.23e-05 | 6 | 43 | 2 | 17893151 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 11788586 | ||
| Pubmed | Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins. | 2.23e-05 | 6 | 43 | 2 | 23088536 | |
| Pubmed | SIPP1, a novel pre-mRNA splicing factor and interactor of protein phosphatase-1. | 2.23e-05 | 6 | 43 | 2 | 14640981 | |
| Pubmed | Protein kinase C [micro] is regulated by the multifunctional chaperon protein p32. | 2.23e-05 | 6 | 43 | 2 | 10831594 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 10879655 | ||
| Pubmed | The use of fluorescent phorbol esters in studies of protein kinase C-membrane interactions. | 2.23e-05 | 6 | 43 | 2 | 12093536 | |
| Pubmed | An immunohistochemical study of protein kinase C distribution in fetal mouse vertebral column. | 2.23e-05 | 6 | 43 | 2 | 7985811 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 16434393 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 25785436 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 21998301 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 12783114 | ||
| Pubmed | Protein phosphatase 1 regulates the phosphorylation state of the polarity scaffold Par-3. | 2.23e-05 | 6 | 43 | 2 | 18641122 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.49e-05 | 281 | 43 | 5 | 28706196 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 15381704 | ||
| Pubmed | PKC-alpha regulates cardiac contractility and propensity toward heart failure. | 3.12e-05 | 7 | 43 | 2 | 14966518 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 7588787 | ||
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 12147701 | ||
| Pubmed | Association of a protein phosphatase 1 activity with the human factor C1 (HCF) complex. | 3.12e-05 | 7 | 43 | 2 | 10637318 | |
| Pubmed | Functional association of cytokine-induced SH2 protein and protein kinase C in activated T cells. | 3.12e-05 | 7 | 43 | 2 | 12618484 | |
| Pubmed | Polycystin-1 binds Par3/aPKC and controls convergent extension during renal tubular morphogenesis. | 3.12e-05 | 7 | 43 | 2 | 24153433 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 12056906 | ||
| Pubmed | Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. | 3.12e-05 | 7 | 43 | 2 | 18689497 | |
| Pubmed | SARP, a new alternatively spliced protein phosphatase 1 and DNA interacting protein. | 3.12e-05 | 7 | 43 | 2 | 17123353 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 12391145 | ||
| Interaction | AKAP9 interactions | 6.13e-06 | 221 | 42 | 6 | int:AKAP9 | |
| Interaction | KCTD20 interactions | 1.09e-05 | 21 | 42 | 3 | int:KCTD20 | |
| Interaction | BTBD10 interactions | 1.26e-05 | 22 | 42 | 3 | int:BTBD10 | |
| Interaction | PPP1R2C interactions | 2.54e-05 | 4 | 42 | 2 | int:PPP1R2C | |
| Interaction | CSRNP2 interactions | 4.22e-05 | 5 | 42 | 2 | int:CSRNP2 | |
| Interaction | PPP1R14B interactions | 4.81e-05 | 34 | 42 | 3 | int:PPP1R14B | |
| Interaction | PRKCH interactions | 5.26e-05 | 35 | 42 | 3 | int:PRKCH | |
| Interaction | SFRP5 interactions | 6.33e-05 | 6 | 42 | 2 | int:SFRP5 | |
| Interaction | AKAP11 interactions | 6.44e-05 | 104 | 42 | 4 | int:AKAP11 | |
| Interaction | SHANK3 interactions | 6.71e-05 | 496 | 42 | 7 | int:SHANK3 | |
| Interaction | PPP1R15A interactions | 7.88e-05 | 40 | 42 | 3 | int:PPP1R15A | |
| Interaction | AKAP13 interactions | 9.85e-05 | 116 | 42 | 4 | int:AKAP13 | |
| Interaction | C12orf57 interactions | 1.12e-04 | 45 | 42 | 3 | int:C12orf57 | |
| Interaction | RORC interactions | 1.12e-04 | 45 | 42 | 3 | int:RORC | |
| Interaction | CCNE1 interactions | 1.16e-04 | 121 | 42 | 4 | int:CCNE1 | |
| Interaction | CD2BP2 interactions | 1.16e-04 | 232 | 42 | 5 | int:CD2BP2 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.49e-04 | 13 | 33 | 2 | 693 | |
| GeneFamily | EF-hand domain containing | 6.51e-04 | 219 | 33 | 4 | 863 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 4.90e-07 | 162 | 43 | 5 | 91cc14aec8d580cf97a1929bc1acb00fcbcdb57a | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.04e-07 | 169 | 43 | 5 | 319511ea57bbd72c2d95e8516d093689df67a912 | |
| ToppCell | distal-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.39e-06 | 200 | 43 | 5 | 2fc1e95706f212bf18ecdf6eb5b3182ac98c9b52 | |
| ToppCell | Mild/Remission-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.48e-06 | 134 | 43 | 4 | 5bd1e3fa6278facd9e949e9e5e244e700190126b | |
| ToppCell | Mild/Remission-B_intermediate-14|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.04e-05 | 141 | 43 | 4 | 69e32125a0e8f0c8561e5e7a93607f368f09546f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 164 | 43 | 4 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 164 | 43 | 4 | a67dd181eba275c191f4d0cab13df30eaa3ad913 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-05 | 167 | 43 | 4 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-05 | 167 | 43 | 4 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-05 | 167 | 43 | 4 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-05 | 167 | 43 | 4 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 170 | 43 | 4 | 82ccba6ec53f6ca0d19949a1277434c565af2983 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 170 | 43 | 4 | ab19ea729ed8c8361c870e79893d1a95a1e487fa | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 178 | 43 | 4 | 8b7df6ab8709d9ab9dff97677cc4561aec2745bc | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 178 | 43 | 4 | 58857bb8c13e0e1c6d9f5c1258f00fff62063d68 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 178 | 43 | 4 | b0baf5667e3301898b3e45e974b8a8530af6a338 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-05 | 181 | 43 | 4 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-05 | 181 | 43 | 4 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 183 | 43 | 4 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 183 | 43 | 4 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.95e-05 | 184 | 43 | 4 | 2df903924df9cb71039159416bcbe6a6614e21fe | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.01e-05 | 185 | 43 | 4 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 3.01e-05 | 185 | 43 | 4 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.08e-05 | 186 | 43 | 4 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-05 | 187 | 43 | 4 | e61992de4f98eeea08b43213850769d923f8db48 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 187 | 43 | 4 | 6288da8cdd450c58df00ebcfcc118f01fab7e610 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.21e-05 | 188 | 43 | 4 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.21e-05 | 188 | 43 | 4 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 189 | 43 | 4 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | droplet-Lung-1m-Epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-05 | 189 | 43 | 4 | 72ecd5a10e419bac475e22f5b602e7f008835ce9 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 189 | 43 | 4 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 189 | 43 | 4 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 3.34e-05 | 190 | 43 | 4 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.41e-05 | 191 | 43 | 4 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.41e-05 | 191 | 43 | 4 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-05 | 191 | 43 | 4 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.41e-05 | 191 | 43 | 4 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-05 | 191 | 43 | 4 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.41e-05 | 191 | 43 | 4 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.41e-05 | 191 | 43 | 4 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.41e-05 | 191 | 43 | 4 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-05 | 191 | 43 | 4 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.48e-05 | 192 | 43 | 4 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-05 | 192 | 43 | 4 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | ASK428-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.48e-05 | 192 | 43 | 4 | 356ebddd03aec341b79890977edb8ff0804999a1 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.55e-05 | 193 | 43 | 4 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.55e-05 | 193 | 43 | 4 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-05 | 193 | 43 | 4 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.55e-05 | 193 | 43 | 4 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.63e-05 | 194 | 43 | 4 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.63e-05 | 194 | 43 | 4 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 3.63e-05 | 194 | 43 | 4 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.70e-05 | 195 | 43 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|Epithelial_cells / Location, Cell class and cell subclass | 3.70e-05 | 195 | 43 | 4 | a3e2999fdd4c3575add6e28ecfd1d6606a61f992 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 43 | 4 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 43 | 4 | 2d19148df56e99f66b596af2d7f9d0f10f9a9087 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 43 | 4 | cd6cfe3ef150a4a4575e04fc8a8213cdceefa1c4 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.70e-05 | 195 | 43 | 4 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 43 | 4 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.70e-05 | 195 | 43 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.70e-05 | 195 | 43 | 4 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 43 | 4 | e22ca35bea06aa95ff2cc771632969f5e7229ffc | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.70e-05 | 195 | 43 | 4 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 43 | 4 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.70e-05 | 195 | 43 | 4 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 43 | 4 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 3.70e-05 | 195 | 43 | 4 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-05 | 195 | 43 | 4 | 43f0c257e4bb5c627afbdfc695c1199c672842d3 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.77e-05 | 196 | 43 | 4 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.77e-05 | 196 | 43 | 4 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.77e-05 | 196 | 43 | 4 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.77e-05 | 196 | 43 | 4 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.77e-05 | 196 | 43 | 4 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.77e-05 | 196 | 43 | 4 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.77e-05 | 196 | 43 | 4 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.77e-05 | 196 | 43 | 4 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.85e-05 | 197 | 43 | 4 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.85e-05 | 197 | 43 | 4 | 009dc732c43bfdc0d5a662b2c7d1a7a86b0d1d24 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.85e-05 | 197 | 43 | 4 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.85e-05 | 197 | 43 | 4 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.93e-05 | 198 | 43 | 4 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 3.93e-05 | 198 | 43 | 4 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.93e-05 | 198 | 43 | 4 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | distal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 7e5f29f4ec1fea92f2c0064eea151d2d474ef904 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | distal-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | 97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60 | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.00e-05 | 199 | 43 | 4 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.08e-05 | 200 | 43 | 4 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.08e-05 | 200 | 43 | 4 | d5426cd318a8f90c0bd8f9804351ab230fafc995 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.08e-05 | 200 | 43 | 4 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | medial-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.08e-05 | 200 | 43 | 4 | 0079041c3e654c1ef77c492bdb2f31ce8f4b507b | |
| Drug | tautomycin | 8.89e-08 | 118 | 43 | 6 | CID000440646 | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 9.21e-06 | 28 | 43 | 3 | DOID:7998 (biomarker_via_orthology) | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 3.10e-05 | 6 | 43 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | psychotic symptoms | 1.74e-04 | 74 | 43 | 3 | EFO_0005940 | |
| Disease | Cardiac Hypertrophy | 2.36e-04 | 82 | 43 | 3 | C1383860 | |
| Disease | Cardiomegaly | 2.36e-04 | 82 | 43 | 3 | C0018800 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 5.15e-04 | 107 | 43 | 3 | DOID:6000 (biomarker_via_orthology) | |
| Disease | smoking cessation | 1.27e-03 | 325 | 43 | 4 | EFO_0004319 | |
| Disease | susceptibility to bacterial meningitis measurement | 2.63e-03 | 52 | 43 | 2 | EFO_0008411 | |
| Disease | Metastatic melanoma | 2.83e-03 | 54 | 43 | 2 | C0278883 | |
| Disease | Nonorganic psychosis | 4.57e-03 | 69 | 43 | 2 | C0349204 | |
| Disease | Bipolar Disorder | 5.06e-03 | 477 | 43 | 4 | C0005586 | |
| Disease | IGF-1 measurement | 5.48e-03 | 488 | 43 | 4 | EFO_0004627 | |
| Disease | Antihypertensive use measurement | 6.78e-03 | 265 | 43 | 3 | EFO_0009927 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CAMAMFGYMTDTGTV | 56 | Q8IWT0 | |
| ESMGSEDMLFMLYTS | 281 | Q9NUB1 | |
| EDMLFMLYTSGSTGM | 286 | Q9NUB1 | |
| FMENIMFCGMGGFSD | 251 | Q6UX73 | |
| LMLIDASFGFEMEMF | 46 | Q5VTM2 | |
| GDMTNEEFRQMMGCF | 81 | O60911 | |
| GDVGTGKTMVMDMFY | 136 | Q8WV93 | |
| ISGRMIGQFMFDTMG | 486 | Q008S8 | |
| PVNTFSLFDEFMEMM | 531 | A1A5B4 | |
| MENMVTVGFFSCMGT | 156 | Q9NPC2 | |
| FTFAMGFMTGTISSM | 171 | Q969X1 | |
| ATDMFLAVMRFMGDA | 3071 | Q9UKN7 | |
| GEVTDGMMDTKMVHF | 306 | Q96A33 | |
| SENLTDFLMEMGFRM | 111 | Q9BUE0 | |
| FDNAGAMMSVDETLM | 276 | P62136 | |
| MGMGDLLSAMFDFSE | 511 | P20393 | |
| MEMGLSIEEALMYSF | 221 | Q9P2J9 | |
| MFEMMDSSGRGTISF | 71 | A6NFE3 | |
| ILDVMDMTIFDFLMG | 441 | Q8IXL6 | |
| DLAGFKMMEMFGLVE | 1226 | Q05707 | |
| EMMFGSVAMSYKGST | 131 | Q8TF40 | |
| EGMFRDMSISNTTMD | 471 | Q13618 | |
| MEMSGLSFSEMEGCR | 1 | Q5JPI3 | |
| GKMFEMTRSGAIDMS | 3606 | Q12955 | |
| MSMAVETFGFFMATV | 1 | P56746 | |
| DRAVMLGFAMMGFSV | 56 | Q9NPA1 | |
| EMLRVGFMMSVAVGF | 271 | Q9HBR0 | |
| IRGAGMDMVFFADAM | 2921 | Q8TE73 | |
| MSESGEMSEFGYIME | 1 | Q9NQ86 | |
| MAEGEDMQTFTSIMD | 1 | Q7Z4K8 | |
| DFGMCKEHMMDGVTT | 481 | P17252 | |
| IEMMKLMGFASFDST | 101 | Q8WVK2 | |
| GIFTTMTGMAMTAFA | 331 | Q7Z3Q1 | |
| MFTEGELMSVGMDTF | 11 | Q15831 | |
| FLDMFSVMSEMAPRD | 91 | Q96Q77 | |
| FGMTDDMIMDRVFRG | 61 | Q9HAE3 | |
| CAGMFKTMVAFDMDG | 586 | Q5VZE5 | |
| ITDRVEMGQMASMFF | 126 | Q8NE00 | |
| EMGQMASMFFNKVGV | 131 | Q8NE00 | |
| MELFHMTSGGDAAMF | 1926 | Q6ZS81 | |
| ADFGTCMKMDETGMV | 231 | O75116 | |
| SMDEFMSITGSLDMA | 846 | Q2NKQ1 | |
| FDNAGAMMSVDETLM | 276 | P36873 | |
| MLDRDMSGTMGFNEF | 81 | P30626 | |
| MFEMMAGRSPFDIIT | 441 | Q05513 |